AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:SURFSurface Oncology News Headlines

$4.69
-0.12 (-2.49 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.62
Now: $4.69
$5.04
50-Day Range
$1.67
MA: $2.88
$5.95
52-Week Range
$1.15
Now: $4.69
$7.66
Volume989,925 shs
Average Volume1.23 million shs
Market Capitalization$132.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Headlines

Surface Oncology (NASDAQ SURF) News Headlines

Source:
DateHeadline
Surface Oncology -2.1% after equity sales agreementSurface Oncology -2.1% after equity sales agreement
seekingalpha.com - May 22 at 7:40 PM
P/E Ratio Insights for Surface OncologyP/E Ratio Insights for Surface Oncology
finance.yahoo.com - May 20 at 3:01 PM
Why Surface Oncologys Stock Is Surging HigherWhy Surface Oncology's Stock Is Surging Higher
www.benzinga.com - May 20 at 1:00 PM
Thinking about buying stock in Surface Oncology, Inovio Pharmaceuticals, American Airlines, Altimmune, or Aurora Cannabis?Thinking about buying stock in Surface Oncology, Inovio Pharmaceuticals, American Airlines, Altimmune, or Aurora Cannabis?
www.prnewswire.com - May 20 at 10:01 AM
Surface Oncology teams up with Merck in cancer study; shares up 35%Surface Oncology teams up with Merck in cancer study; shares up 35%
seekingalpha.com - May 20 at 10:01 AM
Surface Oncology Fully Utilizes its $30M At-the-Market FacilitySurface Oncology Fully Utilizes its $30M At-the-Market Facility
finance.yahoo.com - May 20 at 10:01 AM
Surface Oncology Inc (NASDAQ:SURF) Short Interest UpdateSurface Oncology Inc (NASDAQ:SURF) Short Interest Update
www.americanbankingnews.com - May 18 at 10:10 PM
Upgrade: Analysts Just Made A Massive Increase To Their Surface Oncology, Inc. (NASDAQ:SURF) ForecastsUpgrade: Analysts Just Made A Massive Increase To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts
finance.yahoo.com - May 15 at 1:31 PM
Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual MeetingSurface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
finance.yahoo.com - May 15 at 8:30 AM
Surface Oncology to Present at the American Society of Clinical Oncology Annual MeetingSurface Oncology to Present at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 14 at 9:41 AM
Surface Oncology (NASDAQ:SURF) Releases  Earnings Results, Beats Estimates By $0.31 EPSSurface Oncology (NASDAQ:SURF) Releases Earnings Results, Beats Estimates By $0.31 EPS
www.americanbankingnews.com - May 13 at 7:42 PM
Surface Oncology EPS beats by $0.54, beats on revenueSurface Oncology EPS beats by $0.54, beats on revenue
seekingalpha.com - May 12 at 8:08 AM
Surface Oncology Inc (SURF) to Report Q1 Results: Wall Street Expects Earnings GrowthSurface Oncology Inc (SURF) to Report Q1 Results: Wall Street Expects Earnings Growth
finance.yahoo.com - May 7 at 2:54 PM
Surface Oncology launches early-stage study of cancer candidate SRF388Surface Oncology launches early-stage study of cancer candidate SRF388
seekingalpha.com - April 23 at 1:42 PM
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
finance.yahoo.com - April 23 at 8:42 AM
BRIEF-Surface Oncology Announces First Patient Dosed In Clinical Trial Of Immuno-Oncology Candidate SRF617BRIEF-Surface Oncology Announces First Patient Dosed In Clinical Trial Of Immuno-Oncology Candidate SRF617
www.reuters.com - March 18 at 12:55 AM
Surface Oncology up 4% on start of SRF617 studySurface Oncology up 4% on start of SRF617 study
seekingalpha.com - March 17 at 2:54 PM
Earnings Beat: Surface Oncology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsEarnings Beat: Surface Oncology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
finance.yahoo.com - March 12 at 2:23 PM
Surface Oncology EPS in-line, misses on revenueSurface Oncology EPS in-line, misses on revenue
seekingalpha.com - March 10 at 9:08 AM
Is Surface Oncology (SURF) Outperforming Other Medical Stocks This Year?Is Surface Oncology (SURF) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - March 6 at 12:45 PM
Surface Oncology to Present at the 40th Annual Cowen Healthcare ConferenceSurface Oncology to Present at the 40th Annual Cowen Healthcare Conference
finance.yahoo.com - February 25 at 7:58 PM
Molecular Partners AG: Molecular Partners Announces Newly Nominated Board Members for Upcoming Annual MeetingMolecular Partners AG: Molecular Partners Announces Newly Nominated Board Members for Upcoming Annual Meeting
www.finanznachrichten.de - February 20 at 7:29 AM
Is Surface Oncology (SURF) Stock Outpacing Its Medical Peers This Year?Is Surface Oncology (SURF) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - February 19 at 2:42 PM
Surface Oncology, Inc. (SURF) Shares March Higher, Can It Continue?Surface Oncology, Inc. (SURF) Shares March Higher, Can It Continue?
finance.yahoo.com - February 4 at 8:54 AM
The Daily Biotech Pulse: Accelerons Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into ClinicsThe Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
www.benzinga.com - January 28 at 9:38 AM
Surface Oncology to advance two candidates into the clinic; shares up 9% premarketSurface Oncology to advance two candidates into the clinic; shares up 9% premarket
seekingalpha.com - January 28 at 9:38 AM
Surface Oncology +14% as FDA clears two INDsSurface Oncology +14% as FDA clears two INDs
seekingalpha.com - January 27 at 10:45 PM
BRIEF-Surface Oncology Says Board Approved Corporate RestructuringBRIEF-Surface Oncology Says Board Approved Corporate Restructuring
www.msn.com - January 27 at 10:45 PM
BRIEF-Surface Oncology Announces FDA Clearance Of SRF617 And SRF388 INDs To Initiate Phase 1 Clinical TrialsBRIEF-Surface Oncology Announces FDA Clearance Of SRF617 And SRF388 INDs To Initiate Phase 1 Clinical Trials
www.msn.com - January 27 at 5:44 PM
Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical TrialsSurface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials
finance.yahoo.com - January 27 at 5:44 PM
Did Hedge Funds Drop The Ball On Surface Oncology, Inc. (SURF) ?Did Hedge Funds Drop The Ball On Surface Oncology, Inc. (SURF) ?
finance.yahoo.com - December 23 at 1:31 PM
Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx ConferenceSurface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
finance.yahoo.com - November 26 at 8:19 AM
BRIEF-Surface Oncology Announces $25 Mln Debt Financing From K2 HealthVenturesBRIEF-Surface Oncology Announces $25 Mln Debt Financing From K2 HealthVentures
www.msn.com - November 25 at 7:58 PM
Surface Oncology receives $25M in debt financingSurface Oncology receives $25M in debt financing
seekingalpha.com - November 25 at 2:57 PM
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVenturesSurface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
finance.yahoo.com - November 25 at 2:57 PM
Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D DaySurface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
finance.yahoo.com - November 18 at 8:22 AM
Surface Oncology, Inc. (SURF) Reports Q3 Loss, Lags Revenue EstimatesSurface Oncology, Inc. (SURF) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 12 at 1:07 PM
Surface Oncology EPS misses by $0.03, misses on revenueSurface Oncology EPS misses by $0.03, misses on revenue
seekingalpha.com - November 12 at 8:06 AM
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019
finance.yahoo.com - November 12 at 8:06 AM
Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual MeetingSurface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual Meeting
finance.yahoo.com - November 7 at 12:19 PM
Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURFKaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURF
finance.yahoo.com - October 26 at 11:04 PM
Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York CitySurface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City
finance.yahoo.com - October 7 at 9:03 AM
Heres Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash WiselyHere's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
finance.yahoo.com - September 23 at 4:40 PM
Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash WiselyHere's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
finance.yahoo.com - September 23 at 4:40 PM
IPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the FirmIPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
finance.yahoo.com - September 18 at 7:03 PM
The global CTLA4 inhibitors market at a CAGR of over 9% during the forecast periodThe global CTLA4 inhibitors market at a CAGR of over 9% during the forecast period
www.benzinga.com - September 11 at 4:46 PM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the FirmIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
finance.yahoo.com - September 3 at 4:13 PM
Surface Oncology to Present at the Baird 2019 Global Healthcare ConferenceSurface Oncology to Present at the Baird 2019 Global Healthcare Conference
finance.yahoo.com - September 3 at 4:13 PM
Ramy Ibrahim, M.D. to Join Surface Oncology Board of DirectorsRamy Ibrahim, M.D. to Join Surface Oncology Board of Directors
finance.yahoo.com - September 3 at 12:39 PM
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 28 at 4:49 PM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.